Wire Stories
-
380Atom Bioscience Raises $83M in a D-Round Financing to Support Global Pivotal Clinical Trials of ABP-671, a New Treatment for Chronic Gout
JIANGSU, China–(BUSINESS WIRE)–Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and...
-
486T-Mobile US and Deutsche Telekom Global Carrier Complete Testing of World’s First 5G Standalone Roaming Program with AIS and Sunrise
BELLEVUE, Wash. & BONN, Germany–(BUSINESS WIRE)–T-Mobile US, Inc. (NASDAQ: TMUS): What’s the news: T-Mobile US and Deutsche Telekom Global Carrier have completed...
-
412MUST Connect 2023 Singapore highlighted the cutting-edge innovations of Korean life science startups
Twelve promising Korean startups to showcase their products and growth plans to global pharmaceutical companies and investors SINGAPORE–(BUSINESS WIRE)–#ABLELabs–MUST Connect 2023...
-
392Digital Literacy Projects Define TDCX Foundation’s First Year
SINGAPORE–(BUSINESS WIRE)–TDCX Foundation, the social impact arm of TDCX (NYSE: TDCX), an award-winning digital customer experience (CX) solutions provider for technology and...
-
397Wolters Kluwer accounting industry survey reveals revenue growth remains key focus in APAC region
Survey finds that accounting firms embracing innovation, technology and cloud solutions will thrive SYDNEY–(BUSINESS WIRE)–Wolters Kluwer, a global leader in professional information,...
-
450HKTB Invites Visitors and Locals to “Hallo” Hong Kong Halloween
Explore the City for Hot-Spot Hunting and Night-Time Celebration HONG KONG–(BUSINESS WIRE)–Look out for adorable Halloween friends across Hong Kong! Smiley pumpkins,...
-
335Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
BEIJING, China–(BUSINESS WIRE)–Avistone Biotechnology Co., Ltd (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, today announced results...
-
378Stronghold Announces Bitcoin Mining Update and Frontier Managed Services Agreement
NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, or the “Company”) today provided the following...
-
401Shaperon Inc. Makes a Splash at BioFuture™ 2023 With the Announcement of US Subsidiary Hudson Therapeutics Inc. and Positive Clinical Data
CAMBRIDGE, Mass. & SEOUL, South Korea–(BUSINESS WIRE)–Shaperon Inc. grabbed the spotlight at BioFuture™ 2023 as it confidently graced the stage, delivering a...
-
591BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) in Relapsed or Refractory Follicular Lymphoma
CHMP recommends approval for BRUKINSA plus obinutuzumab as a treatment for adult patients who have received at least two prior lines of...
